EUCTR2015-002440-13-AT进行中（未招募）1 期
Treatment satisfaction and self-reported symptoms in patients under opioid maintenance therapy - Satisfaction with OMT
Medical University Innsbruck0 个研究点开始时间: 2015年11月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Medical or compliance-related psychological or social-environmental reasons for OMT optimization as determined by routine clinical screening procedure
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Severe psychiatric condition (e.g. psychosis, suicidality, depression, over aggressive or dissocial behavior) preventing study participation and systematic acquisition of the study-relevant data
研究者
相似试验
已完成
Unknown
Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000053067Kimitsu Chuo Hospital103
已完成
不适用
Assessing patient satisfaction following treatment with sodium glucose co-transporter 2 inhibitor for type 1 diabetes mellitustype 1 diabetes mellitusJPRN-UMIN000040487Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital24
已完成
不适用
Patient satisfaction and treatment success rate of implant-retained mandibular overdentureFully edentulous patients.IRCT201112198464N1Islamic azad University22
已完成
不适用
Functional outcomes, treatment satisfaction, decisional regret, and the impact of institutional factors after robotic vs. retropubic radical prostatectomy: a 5 year follow-up of the HAROW studyC61Malignant neoplasm of prostateDRKS00011501Klinik und Poliklinik für UrologieTU Dresden936
进行中（未招募）
1 期
Evaluation of Treatment Satisfaction, Effectiveness and Tolerability in Subjects treated with Low-dose Diclofenac Epolamine Soft Capsules for Acute, Mild or Moderate Musculoskeletal PaiEUCTR2018-004886-15-ITIBSA INSTITUT BIOCHIMIQUE SA200